# reload+after+2024-01-21 07:48:03.374323
address1§2430 North Halsted Street
city§Chicago
state§IL
zip§60614
country§United States
phone§847 673 1700
fax§847 556 6411
website§https://www.exicuretx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Exicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
fullTimeEmployees§7
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Paul  Kang', 'age': 61, 'title': 'CEO & Director', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jiyoung  Hwang', 'age': 46, 'title': 'CFO & Director', 'yearBorn': 1977, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joshua  Miller', 'age': 47, 'title': 'Chief Accounting Officer', 'yearBorn': 1976, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bart  Anderson', 'title': 'Senior Director of R&D', 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§10
compensationRisk§10
shareHolderRightsRisk§7
overallRisk§10
governanceEpochDate§1704067200
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.119
priceToSalesTrailing12Months§0.21288146
currency§USD
dateShortInterest§1702598400
forwardEps§-0.77
exchange§NCM
quoteType§EQUITY
shortName§Exicure, Inc.
longName§Exicure, Inc.
firstTradeDateEpochUtc§1526995800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ee4bcb27-f318-38c7-8572-459785e7d845
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§1.632
grossMargins§0.17617
ebitdaMargins§0.17894
trailingPegRatio§None
